YS Biopharma to change legal name to LakeShore Biopharma

Slightly above 67% of YS Old's investor base is looking to short. The analysis of current outlook of investing in YS Old suggests that many traders are alarmed regarding YS Old's prospects. YS Old's investing sentiment can be driven by a variety of factors including economic data, YS Old's earnings reports, geopolitical events, and overall market trends.
  
YS Biopharma said on Friday that the biopharmaceutical company is changing its legal name to LakeShore Biopharma.

Read at seekingalpha.com
seekingalpha News
  

YS Old Fundamental Analysis

We analyze YS Old's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of YS Old using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of YS Old based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Total Debt

Total Debt Comparative Analysis

YS Old is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

YS Old Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with YS Old stock to make a market-neutral strategy. Peer analysis of YS Old could also be used in its relative valuation, which is a method of valuing YS Old by comparing valuation metrics with similar companies.

Peers

YS Old Related Equities

ZURAZura Bio   13.33   
0%
95.0%
IMMXImmix Biopharma   12.66   
0%
91.0%
SONNSonnet Biotherapeutics   0.65   
0%
4.0%
CNSPCns Pharmaceuticals   0.41   
0%
2.0%
ALLRAllarity Therapeutics   1.23   
8.0%
0%
REVBRevelation Biosciences   1.41   
10.0%
0%
VRAXVirax Biolabs   2.34   
16.0%
0%
ZVSAZyVersa Therapeutics   3.42   
24.0%
0%
BDRXBiodexa Pharmaceticals   3.48   
25.0%
0%
CDIOCardio Diagnostics   8.16   
58.0%
0%
QNRXQuoin Pharmaceuticals   13.89   
100.0%
0%
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Consideration for investing in YS Old Stock

If you are still planning to invest in YS Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the YS Old's history and understand the potential risks before investing.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Stocks Directory
Find actively traded stocks across global markets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years